AIT Strategies Report issue

Foundation Phase 1 Phase 2

Organization Overview

First Clinical Trial
2012
NCT01616303
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now